High prescribing rates of systemic corticosteroids 全身性類固醇 in Taiwan

2025 04 03 Owen Yang

The high prescribing rate of systemic corticosteroid (#H02AB) in Taiwan, near 20% in all ages, has been reported in CTS in 2023 . This is reported to be substantially higher than the US (7%) and Denmark (2%), and possibly mainly driven by short-term prescribing in otherwise healthy individuals.

I think this difference is higher than what could be explained by most demographic-driven disease prevalence, and most likely linked to the practice and patient expectation in Taiwan.